| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2798 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1142 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 877 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 667 | 2021 |
| Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 … M Sholzberg, GH Tang, H Rahhal, M AlHamzah, LB Kreuziger, FN Áinle, ... bmj 375, 2021 | 356 | 2021 |
| Promoter proximal splice sites enhance transcription A Furger, JM O‘Sullivan, A Binnie, BA Lee, NJ Proudfoot Genes & development 16 (21), 2792-2799, 2002 | 349 | 2002 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 298 | 2022 |
| How the COVID-19 pandemic will change the future of critical care YM Arabi, E Azoulay, HM Al-Dorzi, J Phua, J Salluh, A Binnie, C Hodgson, ... Intensive care medicine 47, 282-291, 2021 | 230 | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 207 | 2021 |
| Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... Cmaj 194 (7), E242-E251, 2022 | 168 | 2022 |
| Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers BP de Almeida, JD Apolónio, A Binnie, P Castelo-Branco BMC cancer 19, 1-12, 2019 | 140 | 2019 |
| Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial J Johnstone, M Meade, F Lauzier, J Marshall, E Duan, J Dionne, YM Arabi, ... Jama 326 (11), 1024-1033, 2021 | 130 | 2021 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 119 | 2023 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 97 | 2021 |
| Biomarkers in acute respiratory distress syndrome A Binnie, JLY Tsang, CC dos Santos Current opinion in critical care 20 (1), 47-55, 2014 | 83 | 2014 |
| Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study M Greco, T De Corte, A Ercole, M Antonelli, E Azoulay, G Citerio, ... Intensive care medicine 48 (6), 690-705, 2022 | 69 | 2022 |
| Epigenetics of sepsis A Binnie, JLY Tsang, P Hu, G Carrasqueiro, P Castelo-Branco, ... Critical Care Medicine 48 (5), 745-756, 2020 | 60 | 2020 |
| Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set A Conway Morris, K Kohler, T De Corte, A Ercole, HJ De Grooth, ... Critical care 26 (1), 236, 2022 | 49 | 2022 |
| Epigenetic profiling in severe sepsis: a pilot study of DNA methylation profiles in critical illness A Binnie, CJ Walsh, P Hu, DJ Dwivedi, A Fox-Robichaud, PC Liaw, ... Critical Care Medicine 48 (2), 142-150, 2020 | 48 | 2020 |
| Epigenetic therapy in urologic cancers: an update on clinical trials I Faleiro, R Leao, A Binnie, RA De Mello, AT Maia, P Castelo-Branco Oncotarget 8 (7), 12484, 2016 | 48 | 2016 |
